Nichols & Pratt Advisers LLP Novartis Ag Transaction History

Nichols & Pratt Advisers LLP

  • $1.45 Billion
  • Q2 2024

A detailed history of Nichols & Pratt Advisers LLP transactions in Novartis Ag stock. As of the latest transaction made, Nichols & Pratt Advisers LLP holds 37,802 shares of NVS stock, worth $4.31 Million. This represents 0.28% of its overall portfolio holdings.

Number of Shares
37,802
Previous 43,296 12.69%
Holding current value
$4.31 Million
Previous $4.19 Million 3.92%
% of portfolio
0.28%
Previous 0.29%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 25, 2024
SELL
$92.57 - $107.37 $508,579 - $589,890
-5,494 Reduced 12.69%
37,802 $4.02 Million
Q1 2024

Apr 29, 2024
SELL
$95.27 - $108.47 $252,179 - $287,120
-2,647 Reduced 5.76%
43,296 $4.19 Million
Q4 2023

Feb 07, 2024
SELL
$92.27 - $101.54 $490,968 - $540,294
-5,321 Reduced 10.38%
45,943 $4.64 Million
Q3 2023

Nov 09, 2023
SELL
$94.73 - $105.13 $943,984 - $1.05 Million
-9,965 Reduced 16.27%
51,264 $5.22 Million
Q2 2023

Aug 02, 2023
SELL
$92.52 - $104.91 $5.27 Million - $5.97 Million
-56,952 Reduced 48.19%
61,229 $6.18 Million
Q1 2023

May 03, 2023
SELL
$80.03 - $92.81 $3.17 Million - $3.67 Million
-39,587 Reduced 25.09%
118,181 $10.9 Million
Q4 2022

Feb 03, 2023
SELL
$75.55 - $92.52 $733,439 - $898,184
-9,708 Reduced 5.8%
157,768 $14.3 Million
Q3 2022

Nov 01, 2022
SELL
$74.61 - $87.26 $7.07 Million - $8.26 Million
-94,695 Reduced 36.12%
167,476 $12.7 Million
Q2 2022

Aug 04, 2022
SELL
$80.52 - $93.75 $1.66 Million - $1.94 Million
-20,665 Reduced 7.31%
262,171 $22.2 Million
Q1 2022

May 10, 2022
SELL
$80.11 - $90.62 $585,684 - $662,522
-7,311 Reduced 2.52%
282,836 $24.8 Million
Q4 2021

Feb 08, 2022
SELL
$79.7 - $88.13 $683,826 - $756,155
-8,580 Reduced 2.87%
290,147 $25.4 Million
Q3 2021

Nov 01, 2021
SELL
$81.78 - $95.14 $1.28 Million - $1.49 Million
-15,649 Reduced 4.98%
298,727 $24.5 Million
Q2 2021

Aug 09, 2021
SELL
$85.24 - $94.15 $121,466 - $134,163
-1,425 Reduced 0.45%
314,376 $28.7 Million
Q1 2021

May 11, 2021
SELL
$83.5 - $98.47 $651,383 - $768,164
-7,801 Reduced 2.41%
315,801 $27 Million
Q4 2020

Feb 08, 2021
SELL
$78.07 - $94.43 $481,926 - $582,916
-6,173 Reduced 1.87%
323,602 $30.6 Million
Q3 2020

Nov 10, 2020
SELL
$82.14 - $91.0 $706,568 - $782,782
-8,602 Reduced 2.54%
329,775 $28.7 Million
Q2 2020

Aug 10, 2020
SELL
$80.93 - $91.1 $254,767 - $286,782
-3,148 Reduced 0.92%
338,377 $29.6 Million
Q1 2020

Apr 24, 2020
BUY
$70.67 - $99.01 $131,799 - $184,653
1,865 Added 0.55%
341,525 $28.1 Million
Q4 2019

Feb 07, 2020
SELL
$84.35 - $95.37 $2.6 Million - $2.94 Million
-30,788 Reduced 8.31%
339,660 $32.2 Million
Q3 2019

Nov 07, 2019
SELL
$85.54 - $94.26 $2.49 Million - $2.75 Million
-29,139 Reduced 7.29%
370,448 $32.2 Million
Q2 2019

Aug 05, 2019
SELL
$75.4 - $92.8 $1.02 Million - $1.26 Million
-13,527 Reduced 3.27%
399,587 $36.5 Million
Q1 2019

Apr 30, 2019
SELL
$75.32 - $86.15 $60,255 - $68,920
-800 Reduced 0.19%
413,114 $39.7 Million
Q4 2018

Feb 08, 2019
SELL
$73.66 - $82.02 $402,772 - $448,485
-5,468 Reduced 1.3%
413,914 $35.5 Million
Q3 2018

Nov 05, 2018
SELL
$66.94 - $77.43 $61,919 - $71,622
-925 Reduced 0.22%
419,382 $36.1 Million
Q2 2018

Jul 27, 2018
SELL
$64.91 - $73.36 $3,440 - $3,888
-53 Reduced 0.01%
420,307 $31.8 Million
Q1 2018

May 11, 2018
BUY
$70.39 - $84.15 $11,403 - $13,632
162 Added 0.04%
420,360 $33.9 Million
Q4 2017

Feb 09, 2018
BUY
$72.33 - $77.64 $81,371 - $87,345
1,125 Added 0.27%
420,198 $35.3 Million
Q3 2017

Nov 08, 2017
SELL
$74.14 - $77.27 $155,323 - $161,880
-2,095 Reduced 0.5%
419,073 $36 Million
Q2 2017

Aug 08, 2017
BUY
N/A
421,168
421,168 $35.2 Million

Others Institutions Holding NVS

# of Institutions
1,426
Shares Held
138M
Call Options Held
1.48M
Put Options Held
1.54M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $245B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Nichols & Pratt Advisers LLP Portfolio

Follow Nichols & Pratt Advisers LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nichols & Pratt Advisers LLP , based on Form 13F filings with the SEC.

News

Stay updated on Nichols & Pratt Advisers LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email